CSL is one of three tier one plasma therapy companies who benefit from an oligopoly in this highly consolidated market. All the players are vertically integrated as plasma sourcing is the most ...
Livewire Markets on MSN
CSL’s mixed half-year: plasma strength offsets vaccine weakness, bright outlook maintained
CSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results